2022
DOI: 10.1016/j.apsb.2022.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Ionic co-aggregates (ICAs) based oral drug delivery: Solubilization and permeability improvement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(3 citation statements)
references
References 53 publications
0
2
0
Order By: Relevance
“…IL-based formulations are also considered potential alternatives for the oral delivery of small molecular hydrophobic drugs. For example, the choline oleate IL-based formulation significantly enhances the absorption of PTX delivered orally compared with the marketed chromophore EL-based formulation [102]. Similarly, the CAGE 1:2-containing formulation has been investigated for the oral delivery of hydrophobic drug sorafenib, resulting in an IL-based formulation with a peak plasma concentration, drug elimination half-life, and mean absorption time 2.2-, 2-, and 1.6-fold higher, respectively, than those of the parent drug suspension (Figure 7A) [97].…”
Section: Bio-ils In Oral Formulation and Deliverymentioning
confidence: 99%
“…IL-based formulations are also considered potential alternatives for the oral delivery of small molecular hydrophobic drugs. For example, the choline oleate IL-based formulation significantly enhances the absorption of PTX delivered orally compared with the marketed chromophore EL-based formulation [102]. Similarly, the CAGE 1:2-containing formulation has been investigated for the oral delivery of hydrophobic drug sorafenib, resulting in an IL-based formulation with a peak plasma concentration, drug elimination half-life, and mean absorption time 2.2-, 2-, and 1.6-fold higher, respectively, than those of the parent drug suspension (Figure 7A) [97].…”
Section: Bio-ils In Oral Formulation and Deliverymentioning
confidence: 99%
“…Our group has successfully developed a novel technique to measure in vivo dissolution by monitoring residual drug particles in the gastrointestinal tract (GIT) of rats through fluorescence-based live imaging . The core of the technique stems from aggregation-caused quenching (ACQ) fluorophores that are physically embedded in crystal lattice to illuminate drug particles. Once the ACQ fluorophores were released due to particle dissolution and came into contact with water, the dye molecules aggregated via π–π stacking, leading to complete quenching of fluorescence. This “on-to-off” switching enables the identification of intact drug particles by eliminating the interference from free fluorophores. The fluorescent intensity was linearly correlated with the concentration of the residual drug particles during dissolution. The residual percentage of fluorescence in rats was recorded with time, which was converted to in vivo dissolution by the difference from 100% (Figure ).…”
Section: Introductionmentioning
confidence: 99%
“…Lipid-based formulations have been a traditional solution to the oral delivery of BC IV drugs [ 14 , 15 , 16 ]. The underlying mechanism is related to intestinal lipolysis, which converts lipids into colloidal structures, including multilamellar and unilamellar vesicles, mixed micelles, and micelles, together with bile salts, phospholipids, and cholesterol [ 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%